article

Biopharma, Processing & Development In-Depth Focus 2018

Posted: 18 December 2018 | | No comments yet

In this supplement: navigating roadblocks to clinical success, and the data challenges of R&D and collaboration.

Biopharma In-Depth Focus

For emerging biotech and small companies in early-stage clinical development, accessing the market as quickly as possible is of paramount importance. Dr. Sébastien Ribault, Muriel Richard and Christian Cattaruzza, from Merck BioReliance End-to-End Solutions, address the key considerations for companies to successfully advance a molecule from the laboratory to the clinic without sacrificing product quality, process efficiency or patient safety.

Many organisations are overwhelmed by all the data they obtain. They struggle to access data when required; they don’t understand the context of the data and relatability of one piece of data to another; and where volumes of data are produced, they can’t decide which data should contribute to decision making and reporting. Unjulie Bhanot, a Solutions Consultant at IDBS, discusses the importance of data management for businesses, and how implementation of a digital platform can reduce any data-related challenges businesses might face.

This In-Depth Focus is restricted - login or subscribe free to access

European Pharmaceutical ReviewThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 

Send this to a friend